PI
LXRX icon

Putnam Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

Putnam Investments’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-41,487
Closed -$595K – 1213
2017
Q1 		$595K Sell
41,487
-5,920
-12% -$87.8K ﹤0.01% 1086
2016
Q4 		$656K Buy
+47,407
New +$761K ﹤0.01% 1085
2014
Q2 		– Sell
-37,175
Closed -$450K – 1493
2014
Q1 		$450K Sell
37,175
-1,903
-5% -$24.3K ﹤0.01% 1368
2013
Q4 		$493K Sell
39,078
-582
-1% -$9.26K ﹤0.01% 1351
2013
Q3 		$658K Sell
39,660
-3,483
-8% -$58.4K ﹤0.01% 1286
2013
Q2 		$655K Buy
+43,143
New +$656K ﹤0.01% 1280

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Putnam Investments's LXRX Position: Q2 2017 in Review

Putnam Investments sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2017, closing a stake of 41,487 shares — an estimated $595K sold.

Putnam Investments first reported a position in LXRX in Q2 2013 and held it in 6 quarters. The position peaked at $658K in Q3 2013. 136 funds tracked by Wall St. Rank hold LXRX as of Q2 2017.

  • Putnam Investments reported no remaining Lexicon Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Putnam Investments sold 41,487 Lexicon Pharmaceuticals shares in Q2 2017, an estimated $595K.
  • Putnam Investments first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Putnam Investments's Lexicon Pharmaceuticals position peaked at $658K in Q3 2013.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2017.

Based on Putnam Investments's 13F filing for Q2 2017, filed 14 Aug 2017.